Table 1 IC50 values of the peptides against bile duct tumour cell and normal cell.

From: Application and mechanism of anticancer peptides in organoid models of intrahepatic cholangiocarcinoma

Peptide

IC50(µM)

HIBEpiC

HCCC-9810

KL-8

2.83 ± 0.01

1.73 ± 0.07

1E

3.02 ± 0.11

8.87 ± 0.01

2E

9.29 ± 0.18

6.96 ± 0.05

5E

6.14 ± 0.02

9.40 ± 0.03

6E

535.07 ± 2.96

325.33 ± 2.88

9E

66.82 ± 2.04

24.55 ± 0.55

10E

16.23 ± 0.02

8.32 ± 0.09

13E

18.77 ± 0.08

10.24 ± 0.04

14E

7.58 ± 0.06

4.51 ± 0.02

14Aad

6.39 ± 0.14

5.08 ± 0.02

Gemcitabine

12.61 ± 0.12

2.03 ± 0.04